Qiagen NV | QIA - Net Income


Qiagen NV reported $68.04M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.01M 153K Mar/2026
argenx SE USD 472M 106M Jun/2026
Avita Medical AUD -11.62M 1.7M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD 146M 351M Mar/2026
Qiagen NV USD 68.04M 39.79M Mar/2026
Revvity USD 51.82M 11.1M Jun/2026
Tectonic Therapeutic USD -25.24M 6.02M Mar/2026
Viatris USD -118.8M 295.2M Jun/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026